Segantii Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-32,950
| Closed | -$6.31M | – | 90 |
|
|
2023
Q4 | $6.31M | Buy |
32,950
+13,700
| +71% | +$2.62M | 0.33% | 58 |
|
|
2023
Q3 | $3.41M | Sell |
19,250
-9,550
| -33% | -$1.69M | 0.12% | 64 |
|
|
2023
Q2 | $5.47M | Buy |
+28,800
| New | +$5.47M | 0.29% | 55 |
|
|
2019
Q3 | – | Sell |
-98,000
| Closed | -$7.11M | – | 60 |
|
|
2019
Q2 | $7.11M | Buy |
+98,000
| New | +$7.11M | 0.63% | 19 |
|
|
2017
Q2 | – | Sell |
-500
| Closed | -$26K | – | 70 |
|
|
2017
Q1 | $26K | Buy |
+500
| New | +$26K | ﹤0.01% | 351 |
|